Abstract: A drug for the treatment of cerebrovascular disorders associated with insufficient cerebral circulation such as ischemic stroke, which comprises a pharmaceutically effective amount of a pyrazolone compound of structural Formula (I): or a pharmaceutically acceptable salt thereof, or a pseudo-polymorphic form thereof, administered at a controlled dose so that the plasma concentration of unchanged form is kept constant for a predetermined period of time and so that the compound may exhibit a higher effect.

Abstract: Provided is an anti-glare film having excellent anti-glare property, and suppressing white muddiness and scintillation, generation of cracks when attaching the films to polarizing elements and a fabrication process of liquid crystal cells, and changes of an anti-glare property over time. An anti-glare film comprises a light-transmitting substrate; and a diffusion layer having a surface roughness and provided on at least one surface of the light-transmitting substrate, in which the diffusion layer is obtainable by applying, on the at least one surface of the light-transmitting substrate, a coating composition including organic fine particles and a radiation curable binder that includes a (meth)acrylate monomer as an essential component, drying the composition to form a coating, and curing it, the organic fine particles in the diffusion layer have an impregnation layer being impregnated with the radiation curable binder, and the impregnation layer has an average thickness of 0.01 to 1.0 ?m.

Abstract: Provided is an anti-glare film having excellent anti-glare property, and suppressing white muddiness and scintillation, generation of cracks when attaching the films to polarizing elements and a fabrication process of liquid crystal cells, and changes of an anti-glare property over time. An anti-glare film comprises a light-transmitting substrate; and a diffusion layer having a surface roughness and provided on at least one surface of the light-transmitting substrate, in which the diffusion layer is obtainable by applying, on the at least one surface of the light-transmitting substrate, a coating composition including organic fine particles and a radiation curable binder that includes a (meth)acrylate monomer as an essential component, drying the composition to form a coating, and curing it, the organic fine particles in the diffusion layer have an impregnation layer being impregnated with the radiation curable binder, and the impregnation layer has an average thickness of 0.01 to 1.0 ?m.

Abstract: To provide to a method for measuring and examining lithium ions in an aqueous solution of a specimen such as biomaterials or environment samples, by using a lithium reagent composition as a coloration reaction reagent and by visual observing or a simple a colorimeter. The lithium ions measuring method is characterized by contacting the specimen including serum and plasma test sample with an aqueous solution of a lithium reagent composition comprising a tetraphenyl porphyrin compound, a pH regulator and a pH buffer, by irradiating or expose the resulting solution with white light, and by detecting change in color tone by a visual observation or by detecting the sensitivity by a colorimeter.

Abstract: The present invention provides an anti-glare film having an excellent anti-glare property, and sufficiently suppressing white muddiness and scintillation, generation of cracks in a process for attaching the films to polarizing elements and a fabrication process of liquid crystal cells, and changes of an anti-glare property over time, even if the film is used in a high definition display.

Abstract: The present invention provides an antiglare film that has a thin antiglare layer and suppresses generation of scintillation and white muddiness at significantly high levels, while maintaining the hard-coating property and antiglare property, thereby providing favorable high-contrast display images.

Abstract: The present invention provides an inexpensive optical layered body which does not cause interference fringes but excels in hard coat properties, antistatic properties, and antireflection properties. An optical layered body comprises: a light-transmitting substrate; and a hard coat layer (A) and a hard coat layer (B) on one face of the light-transmitting substrate in this order, wherein the hard coat layer (B) has a region (B1) not containing inorganic fine particles and a region (B2) containing inorganic fine particles, in this order from a portion adjacent to the hard coat layer (A), a boundary between the region (B1) not containing inorganic fine particles and the region (B2) containing inorganic fine particles has irregularities, and the inorganic fine particles have a particle size smaller than a visible light wavelength.

Abstract: The invention provides a homocysteine synthase inhibitor useful for the prophylaxis or treatment of diseases involving homocysteine synthase. The homocysteine synthase inhibitor is a compound of the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof.

Abstract: The present invention provides an anti-glare film having an excellent anti-glare property, and sufficiently suppressing white muddiness and scintillation, generation of cracks in a process for attaching the films to polarizing elements and a fabrication process of liquid crystal cells, and changes of an anti-glare property over time, even if the film is used in a high definition display.

Abstract: The invention provides a therapeutic drug for ischemic stroke. The therapeutic drug has the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof, as an active ingredient.

Abstract: The present invention provides an inexpensive optical layered body which does not cause interference fringes but excels in hard coat properties, antistatic properties, and antireflection properties. An optical layered body comprises: a light-transmitting substrate; and a hard coat layer (A) and a hard coat layer (B) on one face of the light-transmitting substrate in this order, wherein the hard coat layer (B) has a region (B1) not containing inorganic fine particles and a region (B2) containing inorganic fine particles, in this order from a portion adjacent to the hard coat layer (A), a boundary between the region (B1) not containing inorganic fine particles and the region (B2) containing inorganic fine particles has irregularities, and the inorganic fine particles have a particle size smaller than a visible light wavelength.

Abstract: The invention provides a homocysteine synthase inhibitor useful for the prophylaxis or treatment of diseases involving homocysteine synthase. The homocysteine synthase inhibitor is a compound of the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof.

Abstract: A polarizing-plate-protecting film is provided, including a polyester film, such as a polyethylene terephthalate film, and an adhesion-facilitating layer formed on one surface of the polyester film, made of a hydrophilic cellulosic resin such as acetyl cellulose. On the other surface of the polyester film, a variety of functional layers, such as a hard coat layer, an anti-glaring layer, and an antireflection layer, are layered. The hard coat layer is a layer formed by curing, with an electron beam, an ionizing-radiation-curable resin into which an ultraviolet light absorber has been incorporated. A polyvinyl alcoholic polarizing film is laminated to the adhesion-facilitating layer of the polarizing-plate-protecting film with a water-based adhesive layer to form a polarizing plate.